German Scientists Develop New AI-Based Mutation Detection System to Monitor Novel COVID-19 and Influenza Strains

Medical News: A groundbreaking new system called VirusWarn could soon change the way health authorities detect and respond to emerging COVID-19 and influenza variants. Developed by researchers from the Genome Competence Center at the Robert Koch Institute in Germany and the Hasso Plattner Institute at the University of Potsdam, this powerful mutation-based early warning platform was built to prioritize concerning virus variants using genomic sequencing data.


German Scientists Develop New AI-Based Mutation Detection System to Monitor Novel COVID-19
and Influenza Strains

The rapid mutation of viruses like SARS-CoV-2 and Influenza A and B has made them formidable public health threats, especially when they evolve to evade immune responses or spread faster. As new variants continue to emerge globally, health officials face challenges in identifying and reacting to them before they become dominant. This Medical News report covers how VirusWarn offers a game-changing solution by detecting potential threats long before traditional methods would catch on.
 
VirusWarn Tracks Mutations That Matter Most
Unlike conventional surveillance tools that often require experts to manually track variant trends or use static lineage classifications, VirusWarn brings automation and speed into the picture. The platform ranks virus samples by their mutation profiles - focusing on changes in key proteins such as the spike protein in SARS-CoV-2 or the hemagglutinin (HA) gene in influenza.
 
The VirusWarn system evaluates mutations based on three main categories:
 
-Mutations of Concern (MOCs): These are changes in the virus genome associated with increased transmissibility, immune evasion, or disease severity.
 
-Regions of Interest (ROIs): These include critical parts of the virus such as receptor-binding sites or antigenic regions.
 
-Private Mutations (PMs): Less understood or isolated mutations that aren’t part of known concerning profiles but could still play a role.
 
It then assigns an alert level to each sequence - color-coded from grey (low concern) to red (high concern) - depending on how many and which types of mutations are detected.
 
Dual Mode Functionality for Flexibility
VirusWarn operates in two powerful modes:
 
-VirusWarn-Manual: Based on carefully crafted rules by virologists and epidemiologists, this mode categorizes variants based on known mutation patterns. It proved extremely effective in tests, successfully flagging 100% of Delta and 97% of Omicron variants in early 2021 data before they were officially labeled as Variants of Concern.
 
-VirusWarn-Auto: Leveraging machine learning, this version identifies variants by learning from positive selection sites - areas of the genome that are evolving due to immune pressure or other factors. Remarkably, this automated method matched the performance of manual curation, showing it could replace expert-labor-intensive processes.
 
The Auto model incorporates classifiers like logistic regression and random forest to determine which variants deserve heightened scrutiny. Even when expert-defined MOCs were replaced by machine-inferred positive selection sites, the system still maintained high accuracy in identifying concerning sequences.
 
Adaptable for Multiple Viruses and Future Threats
Originally built for SARS-CoV-2, VirusWarn has already been adapted to monitor Influenza A (H1N1, H3N2) and Influenza B (Victoria lineage). It includes a feature that adjusts for seasonal mutation trends, ensuring it doesn't overreact to mutations that have become common and fixed in a population over time. For instance, the system effectively refined alerts for H1N1 by masking mutations with over 75% prevalence from previous seasons. This drastically reduced false alerts and improved focus on newly emerging threats.
 
Visual Reporting and Global Scalability
VirusWarn produces interactive HTML reports that include searchable tables, heatmaps, and mutation plots - making it easier for public health labs and surveillance teams to digest complex data quickly. Since the platform is based on Nextflow and can run via Docker or Singularity containers, it's highly scalable and adaptable to other pathogens beyond SARS-CoV-2 and influenza.
 
In validation tests with the German national surveillance network (IMSSC2), VirusWarn accurately flagged concerning variants like XBB, BQ, and BN even before they were officially labeled by the World Health Organization. This early alert capability could prove crucial in preparing timely public health responses and updating vaccine formulations.
 
A New Era in Genomic Surveillance
The research team emphasized that VirusWarn is not just another tracking tool - it’s a proactive mutation-based threat detector. Its adaptability means it could eventually be used to monitor viruses like H5N1, Mpox, and even RSV, provided appropriate mutation and scoring databases are developed.
 
Moreover, the authors noted that while many other predictive tools suffer from performance inflation due to training data overlap or web-only access, VirusWarn’s rigorous separation of training and testing datasets ensures reliable performance.
 
Conclusion
VirusWarn represents a significant step forward in global infectious disease preparedness. By automating the detection of dangerous virus mutations and adapting rapidly to emerging threats, it enables health systems to act faster and smarter. Unlike previous systems that depended heavily on user interaction or expert review, VirusWarn democratizes variant detection through its easy-to-use, highly scalable design.
 
The tool’s ability to identify concerning SARS-CoV-2 variants like Delta and Omicron early, and its expansion to seasonal influenza, positions it as a vital addition to the genomic surveillance arsenal. As viruses continue to evolve and new outbreaks loom, platforms like VirusWarn will be essential in keeping the world one step ahead.
 
The study findings were published in the peer reviewed journal: Computational and Structural Biotechnology Journal
https://www.csbj.org/article/S2001-0370(25)00079-0/fulltext

For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/new-sars-cov-2-bq-1-1-1-variant-with-40-spike-mutations-and-many-other-worrisome-genetic-changes-detected-in-canada
 
https://www.thailandmedical.news/news/sars-cov-2-ba-3-variant-returns-in-south-africa-but-this-time-with-more-than-57-new-mutations
 
https://www.thailandmedical.news/news/the-virus-that-won-t-quit-sars-cov-2-s-lp-8-1-variant-and-its-spawn-lp-8-1-1-causes-new-covid-19-surges
 
https://www.thailandmedical.news/articles/coronavirus
 
https://www.thailandmedical.news/pages/thailand_doctors_listings